- Home
- NOTV vs SRTS Comparison
NOTV vs SRTS Comparison
Compare NOTV & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- SRTS
- Stock Information
- Founded
- NOTV 1974
- SRTS 2010
- Country
- NOTV United States
- SRTS United States
- Employees
- NOTV N/A
- SRTS N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- SRTS Medical/Dental Instruments
- Sector
- NOTV Health Care
- SRTS Health Care
- Exchange
- NOTV Nasdaq
- SRTS Nasdaq
- Market Cap
- NOTV 46.7M
- SRTS 52.9M
- IPO Year
- NOTV 1997
- SRTS 2016
- Fundamental
- Price
- NOTV $1.43
- SRTS $3.45
- Analyst Decision
- NOTV Strong Buy
- SRTS Strong Buy
- Analyst Count
- NOTV 1
- SRTS 3
- Target Price
- NOTV $5.00
- SRTS $8.00
- AVG Volume (30 Days)
- NOTV 342.4K
- SRTS 84.8K
- Earning Date
- NOTV 12-02-2025
- SRTS 11-13-2025
- Dividend Yield
- NOTV N/A
- SRTS N/A
- EPS Growth
- NOTV N/A
- SRTS N/A
- EPS
- NOTV N/A
- SRTS N/A
- Revenue
- NOTV $505,299,000.00
- SRTS $37,564,000.00
- Revenue This Year
- NOTV $5.64
- SRTS N/A
- Revenue Next Year
- NOTV $5.16
- SRTS $47.33
- P/E Ratio
- NOTV N/A
- SRTS N/A
- Revenue Growth
- NOTV 0.85
- SRTS 3.29
- 52 Week Low
- NOTV $1.15
- SRTS $3.03
- 52 Week High
- NOTV $6.48
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- NOTV 44.87
- SRTS 51.40
- Support Level
- NOTV $1.25
- SRTS $3.16
- Resistance Level
- NOTV $1.55
- SRTS $3.68
- Average True Range (ATR)
- NOTV 0.12
- SRTS 0.15
- MACD
- NOTV 0.01
- SRTS 0.03
- Stochastic Oscillator
- NOTV 43.24
- SRTS 52.56
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.